These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 19165765

  • 41. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.
    Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T.
    J Biol Chem; 2006 Jul 21; 281(29):20213-20. PubMed ID: 16707486
    [Abstract] [Full Text] [Related]

  • 42. Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.
    Yoshida Y, Yamagishi S, Matsui T, Jinnouchi Y, Fukami K, Imaizumi T, Yamakawa R.
    Diabetes Metab Res Rev; 2009 Oct 21; 25(7):678-86. PubMed ID: 19685553
    [Abstract] [Full Text] [Related]

  • 43. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor.
    Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF.
    Invest Ophthalmol Vis Sci; 2001 Jun 21; 42(7):1646-52. PubMed ID: 11381073
    [Abstract] [Full Text] [Related]

  • 44. Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
    Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Okuda S, Imaizumi T.
    Ophthalmic Res; 2008 Jun 21; 40(1):10-5. PubMed ID: 18025836
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Pigment epithelium-derived factor (PEDF) prevents advanced glycation end products (AGEs)-elicited endothelial nitric oxide synthase (eNOS) reduction through its anti-oxidative properties.
    Yamagishi S, Ueda S, Matsui T, Nakamura K, Imaizumi T, Takeuchi M, Okuda S.
    Protein Pept Lett; 2007 Jun 21; 14(8):832-5. PubMed ID: 17979828
    [Abstract] [Full Text] [Related]

  • 48. Effect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathy.
    Shen X, Xie B, Cheng Y, Jiao Q, Zhong Y.
    Ocul Immunol Inflamm; 2011 Aug 21; 19(4):246-54. PubMed ID: 21770802
    [Abstract] [Full Text] [Related]

  • 49. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ.
    Clin Exp Pharmacol Physiol; 2009 Mar 21; 36(3):287-96. PubMed ID: 19018797
    [Abstract] [Full Text] [Related]

  • 50. Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE)-induced hepatic insulin resistance in vitro by suppressing Rac-1 activation.
    Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, Koga H, Ueno T, Sata M.
    Horm Metab Res; 2008 Sep 21; 40(9):620-5. PubMed ID: 18792873
    [Abstract] [Full Text] [Related]

  • 51. Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats.
    Oturai PS, Christensen M, Rolin B, Pedersen KE, Mortensen SB, Boel E.
    Metabolism; 2000 Aug 21; 49(8):996-1000. PubMed ID: 10954016
    [Abstract] [Full Text] [Related]

  • 52. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T, Guan M, Xu C, Chen Y, Lu Y.
    Life Sci; 2007 Sep 29; 81(16):1256-63. PubMed ID: 17919663
    [Abstract] [Full Text] [Related]

  • 53. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
    Yamagishi S, Takeuchi M.
    Drugs Exp Clin Res; 2004 Sep 29; 30(4):169-75. PubMed ID: 15553663
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Effect of pigment epithelium-derived factor on glutamate uptake in retinal Muller cells under high-glucose conditions.
    Xie B, Jiao Q, Cheng Y, Zhong Y, Shen X.
    Invest Ophthalmol Vis Sci; 2012 Feb 27; 53(2):1023-32. PubMed ID: 22266516
    [Abstract] [Full Text] [Related]

  • 56. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Inoue H.
    Diabetes Metab Res Rev; 2009 Jan 27; 25(1):52-6. PubMed ID: 18677713
    [Abstract] [Full Text] [Related]

  • 57. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation.
    Nakamura K, Yamagishi S, Matsui T, Yoshida T, Takenaka K, Jinnouchi Y, Yoshida Y, Ueda S, Adachi H, Imaizumi T.
    Am J Pathol; 2007 Jun 27; 170(6):2159-70. PubMed ID: 17525281
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pigment epithelium-derived factor reduces the PDGF-induced migration and proliferation of human aortic smooth muscle cells through PPARγ activation.
    Wang SH, Liang CJ, Wu JC, Huang JJ, Chien HF, Tsai JS, Yen YS, Tseng YC, Lue JH, Chen YL.
    Int J Biochem Cell Biol; 2012 Feb 27; 44(2):280-9. PubMed ID: 22074662
    [Abstract] [Full Text] [Related]

  • 60. The novel P2Y 12 antagonist AZD6140 rapidly and reversibly reduces platelet activation in diabetic rats.
    Flierl U, Schöpp C, Jaitner J, Bauersachs J, Schäfer A.
    Thromb Res; 2010 Mar 27; 125(3):e93-9. PubMed ID: 19846210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.